| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 173 |
| 1 | RITUXIMAB | 145 |
| 2 | CYCLOPHOSPHAMIDE | 137 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 137 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 137 |
| 5 | DEXAMETHASONE | 124 |
| 6 | DEXAMETHASONE 1.5 MG | 124 |
| 7 | METHOTREXATE SODIUM | 115 |
| 8 | METHOTREXATE | 107 |
| 9 | METHYLPREDNISOLONE | 102 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HEPATITIS B IMMUNE GLOBULIN (HUMAN) | 1 | 0.0196 |
| 1 | CLOTRIMAZOLE1% CLOTRIMAZOLE | 1 | 0.0182 |
| 2 | SODIUM TETRADECYL SULFATE | 1 | 0.0182 |
| 3 | NELARABINE | 16 | 0.0164 |
| 4 | RELACORILANT | 1 | 0.0101 |
| 5 | PRAMOXINE HYDROCHLORIDE, MENTHOL | 2 | 0.0094 |
| 6 | HYPOCHLOROUS ACID | 1 | 0.0093 |
| 7 | COLLOIDAL OATMEAL | 2 | 0.0078 |
| 8 | DEXTROSE AND SODIUM CHLORIDE | 1 | 0.0060 |
| 9 | LULICONAZOLE | 1 | 0.0057 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 381 |
| 1 | Alkylating Drug [EPC] | 155 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 150 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 128 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 119 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 107 |
| 6 | Osmotic Laxative [EPC] | 97 |
| 7 | Loop Diuretic [EPC] | 92 |
| 8 | Azole Antifungal [EPC] | 86 |
| 9 | Topoisomerase Inhibitor [EPC] | 81 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunoglobulin [EPC] | 1 | 0.0196 |
| 1 | Hematopoietic Stem Cell Mobilizer [EPC] | 5 | 0.0034 |
| 2 | Interleukin-6 Antagonist [EPC] | 2 | 0.0031 |
| 3 | CD19-directed Chimeric Antigen Receptor [EPC] | 30 | 0.0030 |
| 4 | Asparagine-specific Enzyme [EPC] | 31 | 0.0023 |
| 5 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 3 | 0.0014 |
| 6 | Echinocandin Antifungal [EPC] | 11 | 0.0013 |
| 7 | Allylamine Antifungal [EPC] | 9 | 0.0012 |
| 8 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 5 | 0.0012 |
| 9 | Anthracycline Topoisomerase Inhibitor [EPC] | 3 | 0.0012 |